Aegon Asset Management Uk PLC Johnson & Johnson Transaction History

Aegon Asset Management Uk PLC

$7.34 Billion
Q3 2024

A detailed history of Aegon Asset Management Uk PLC transactions in Johnson & Johnson stock. As of the latest transaction made, Aegon Asset Management Uk PLC holds 650,555 shares of JNJ stock, worth $94 Million. This represents 1.44% of its overall portfolio holdings.

Number of Shares

650,555

Previous 662,779 1.84%

Holding current value

$94 Million

Previous $96.8 Million 8.82%

% of portfolio

1.44%

Previous 1.36%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$145.48 - $167.38 $1.78 Million - $2.05 Million	-12,224 Reduced 1.84%	650,555 $105 Million
Q2 2024 Jul 30, 2024	BUY	$144.38 - $157.78 $37.5 Million - $41 Million	259,758 Added 64.45%	662,779 $96.8 Million
Q1 2024 Apr 18, 2024	BUY	$155.22 - $162.74 $923,093 - $967,814	5,947 Added 1.5%	403,021 $63.8 Million
Q4 2023 Jan 11, 2024	BUY	$145.6 - $158.88 $3.13 Million - $3.42 Million	21,495 Added 5.72%	397,074 $62.2 Million
Q2 2023 Jul 28, 2023	BUY	$154.35 - $166.11 $10.9 Million - $11.8 Million	70,869 Added 23.26%	375,579 $62.1 Million
Q4 2022 Oct 19, 2023	SELL	$160.2 - $179.79 $11.4 Million - $12.7 Million	-70,869 Reduced 18.87%	304,710 $53.8 Million
Q4 2022 Jan 17, 2023	BUY	$160.2 - $179.79 $4.94 Million - $5.55 Million	30,860 Added 11.27%	304,710 $53.8 Million
Q3 2022 Oct 18, 2022	BUY	$161.33 - $179.52 $25.9 Million - $28.8 Million	160,627 Added 141.87%	273,850 $44.8 Million
Q2 2022 Jul 12, 2022	BUY	$168.19 - $186.01 $1.01 Million - $1.12 Million	5,999 Added 5.59%	113,223 $20.1 Million
Q1 2022 Apr 28, 2022	SELL	$158.14 - $179.59 $52.7 Million - $59.9 Million	-333,323 Reduced 75.66%	107,224 $19 Million
Q4 2021 Jan 24, 2022	SELL	$155.93 - $173.01 $248,708 - $275,950	-1,595 Reduced 0.36%	440,547 $75.4 Million
Q3 2021 Oct 28, 2021	SELL	$161.5 - $179.47 $16,473 - $18,305	-102 Reduced 0.02%	442,142 $71.4 Million
Q2 2021 Jul 28, 2021	SELL	$159.48 - $171.07 $827,222 - $887,340	-5,187 Reduced 1.16%	442,244 $72.9 Million
Q1 2021 May 07, 2021	SELL	$153.07 - $170.48 $14.3 Million - $15.9 Million	-93,535 Reduced 17.29%	447,431 $73.5 Million
Q4 2020 Jan 25, 2021	SELL	$137.11 - $157.38 $549,125 - $630,306	-4,005 Reduced 0.73%	540,966 $85 Million
Q3 2020 Oct 30, 2020	BUY	$140.38 - $153.83 $948,828 - $1.04 Million	6,759 Added 1.26%	544,971 $81 Million
Q2 2020 Aug 06, 2020	SELL	$128.81 - $155.51 $18.1 Million - $21.9 Million	-140,598 Reduced 20.71%	538,212 $75.5 Million
Q1 2020 Apr 30, 2020	SELL	$111.14 - $153.99 $3.2 Million - $4.44 Million	-28,820 Reduced 4.07%	678,810 $88.9 Million
Q4 2019 Jan 21, 2020	BUY	$127.5 - $146.44 $1.59 Million - $1.83 Million	12,477 Added 1.79%	707,630 $103 Million
Q3 2019 Oct 21, 2019	SELL	$126.95 - $142.14 $1.4 Million - $1.56 Million	-11,008 Reduced 1.56%	695,153 $90 Million
Q2 2019 Jul 09, 2019	SELL	$131.15 - $144.24 $1.52 Million - $1.67 Million	-11,555 Reduced 1.61%	706,161 $98.2 Million
Q1 2019 Apr 10, 2019	BUY	$125.72 - $139.79 $2 Million - $2.22 Million	15,910 Added 2.27%	717,716 $100 Million
Q4 2018 Jan 14, 2019	BUY	$122.84 - $147.84 $60.4 Million - $72.7 Million	492,035 Added 234.56%	701,806 $90.6 Million
Q3 2018 Oct 11, 2018	BUY	$121.58 - $142.88 $2.46 Million - $2.89 Million	20,222 Added 10.67%	209,771 $29 Million
Q2 2018 Jul 10, 2018	SELL	$119.4 - $131.76 $29.5 Million - $32.6 Million	-247,069 Reduced 56.59%	189,549 $23 Million
Q1 2018 May 09, 2018	SELL	$125.1 - $148.14 $31.4 Million - $37.2 Million	-251,303 Reduced 36.53%	436,618 $55.9 Million
Q4 2017 Jan 12, 2018	SELL	$131.22 - $143.62 $2.27 Million - $2.48 Million	-17,290 Reduced 2.45%	687,921 $96.2 Million
Q3 2017 Nov 08, 2017	BUY	$129.47 - $135.38 $91.3 Million - $95.5 Million	705,211	705,211 $91.7 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $378B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aegon Asset Management Uk PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aegon Asset Management Uk PLC with notifications on news.

Account

Aegon Asset Management Uk PLC Johnson & Johnson Transaction History